Lack of mutations in EGFR in gastroenteropancreatic neuroendocrine tumors.
Gilbert
Judith A
JA
Lloyd
Ricardo V
RV
Ames
Matthew M
MM
D000970:Antineoplastic Agents / Q000627:therapeutic use; D004252:DNA Mutational Analysis; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D066246:ErbB Receptors / Q000235:genetics*; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy / Q000235:genetics; D000077156:Gefitinib; D006801:Humans; D008969:Molecular Sequence Data; D009154:Mutation; D018358:Neuroendocrine Tumors / Q000188:drug therapy / Q000235:genetics*; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000235:genetics*; D011110:Polymorphism, Genetic; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D066246:ErbB Receptors; D000077156:Gefitinib